Breast cancer: Tamoxifen, Raloxifene and Tibolone can also cause serious adverse events - Xagena Medical News

Three drugs that reduce a woman's chance of getting mammary carcinoma also have been shown to cause adverse effects, according to a new report from the Agency for Healthcare Research and Quality ( AHRQ ), US Department of Health & Human Services.

The NIH Is Going to Discover Drugs... Really? - Forbes

In extolling the potential of this approach, Dr. Collins pointed to raloxifene, a drug that was developed as an osteoporosis medicine, but which has become highly useful in breast cancer prevention. What Dr Collins is not saying is that ...

Dropping a Few Pounds Could Lower Breast Cancer Risk - Time

The authors note the findings could also apply to overweight women who are being treated with breast cancer drugs that block estrogen or stop its production, such as tamoxifen, raloxifene and exemestane. These drugs are not recommended for use ...

Kidney mass detected on ultrasound doubles in size over nine months - Monthly Prescribing Reference

Her medications included levothyroxine (Levoxyl, Synthroid) 50 mg, fluoxetine (Prozac) 20 mg, raloxifene (Evista) 60 mg, temazepam (Restoril) 15 mg, docusate 100 mg, acetaminophen/hydrocodone (Vicodin) 7.5 mg/500 mg, calcium carbonate 1,200 mg ...

NIH, companies aim to teach old drugs new tricks - Yahoo Finance

The bone drug raloxifene was found to also help prevent breast cancer. Those discoveries "all have been sort of serendipitous. The idea here is, let's not depend on serendipity," Collins said. In recent years, researchers have identified at the ...

Local Researcher, Surgical Oncologist Receives National Award - Boston University

and demonstrating on a large scale the preventive effects of the drugs tamoxifen and raloxifene in reducing rates of invasive breast cancer.

Allegheny General Hospital Oncologists Explore Effectiveness of Commonly-Prescribed Cholesterol Medicine For Preventing Colon Cancer Recurrence - Healthcanal.com

and the NSABP was the first to demonstrate on a large scale the preventive effects of the drugs tamoxifen and raloxifene in breast cancer. Those interested in finding out more about the NSABP P-5 clinical trial at AGH can call 412.359.6464.

NeuVax Founder Dr. Peoples Eliminates Speculation For Facts - Seekingalpha.com

Companies and/or drugs discussed in this interview: Dendreon's Provenge, Bristol-Myers' (BMY) Yervoy, Eli Lilly's Raloxifene, GlaxoSmithKiline's Tykerb, and Galena BioPharma's NeuVax.

Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - msnbc.com

Pralatrexate (Folotyn), Raloxifene (Evista), Ramucirumab, Ridaforolimus (MK-8669), Sorafenib (Nexavar), Trastuzumab (Herceptin), Trastuzumab biosimilar, Trastuzumab emtansine (T-DM1), Trilostane, Triptorelin, TVAX cancer vaccine, Varlitinib ...

New Tablet for Vulvovaginal Atrophy Shows Endometrial Safety - Medscape News

It also compares favorably to the 3% rate of endometrial proliferation in studies of raloxifene (Evista), Dr. Goldstein noted. In the study, postmenopausal women from 51 sites across the United States were randomized to ospemifene 30 mg or 60 mg or to placebo.